DrugPatentWatch Database Preview
CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF Drug Profile
» See Plans and Pricing
When do Children's Cetirizine Hydrochloride Hives Relief patents expire, and when can generic versions of Children's Cetirizine Hydrochloride Hives Relief launch?
Children's Cetirizine Hydrochloride Hives Relief is a drug marketed by Actavis Mid Atlantic, Amneal Pharms, Athem, Aurobindo Pharma, Cypress Pharm, Lannett Co Inc, Perrigo R And D, Pharm Assoc, Ranbaxy Labs Ltd, Taro, Torrent, Tris Pharma Inc, Jubilant Generics, and Sun Pharm. and is included in fifteen NDAs.
The generic ingredient in CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and thirty-three suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
US ANDA Litigation and Generic Entry Outlook for Children's Cetirizine Hydrochloride Hives Relief
A generic version of CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF was approved as cetirizine hydrochloride by TEVA PHARMS on May 27th, 2008.
Summary for CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF
| US Patents: | 0 |
| Applicants: | 14 |
| NDAs: | 15 |
| Suppliers / Packagers: | 29 |
| Bulk Api Vendors: | 98 |
| Clinical Trials: | 12 |
| Patent Applications: | 1,891 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF at DailyMed |
Recent Clinical Trials for CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Hamad Medical Corporation | Phase 1 |
| Stefania La Grutta, MD | Phase 4 |
| Medical Universtity of Lodz | Phase 4 |
See all CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF clinical trials
US Patents and Regulatory Information for CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Mid Atlantic | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | cetirizine hydrochloride | SYRUP;ORAL | 090378-001 | May 9, 2008 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Perrigo R And D | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | cetirizine hydrochloride | SYRUP;ORAL | 090254-001 | Apr 9, 2008 | OTC | No | No | Start Trial | Start Trial | Start Trial | ||||
| Aurobindo Pharma | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | cetirizine hydrochloride | SYRUP;ORAL | 090750-001 | Feb 2, 2010 | OTC | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
